Matches in Wikidata for { <http://www.wikidata.org/entity/Q99529969> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q99529969 description "clinical trial" @default.
- Q99529969 description "ensayo clínico" @default.
- Q99529969 description "ensayu clínicu" @default.
- Q99529969 description "klinisch onderzoek" @default.
- Q99529969 description "клінічне випробування" @default.
- Q99529969 description "临床试验" @default.
- Q99529969 name "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 name "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 type Item @default.
- Q99529969 label "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 label "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 prefLabel "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 prefLabel "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 P1132 Q99529969-D5D0051A-E3E7-4BA4-A9BE-D6045137348F @default.
- Q99529969 P1476 Q99529969-53081FA6-472B-4656-B77A-571BAA22E76B @default.
- Q99529969 P17 Q99529969-D6CC02AA-D54E-48E6-BDFB-CD8187B7E6E6 @default.
- Q99529969 P2899 Q99529969-5E7AE960-E01C-4282-A4E7-6155D4169B9F @default.
- Q99529969 P3098 Q99529969-E61FC1A7-BE4E-4BA6-AF16-FC1C96B9EDA0 @default.
- Q99529969 P31 Q99529969-53BF4486-C9A0-4E60-A359-3994DCC7A3EE @default.
- Q99529969 P4135 Q99529969-22A508E0-4CDE-4AC4-9F96-025A4C2E9DC5 @default.
- Q99529969 P4844 Q99529969-1BAD22BE-F741-4681-835F-1A666086498C @default.
- Q99529969 P580 Q99529969-F7524773-EDCF-463C-B829-3D4F3034F1C7 @default.
- Q99529969 P582 Q99529969-D8CB0052-A76C-4C16-877E-A294BD9BA84E @default.
- Q99529969 P6099 Q99529969-07283ABC-869D-4E78-9FD9-E04F7105301C @default.
- Q99529969 P8005 Q99529969-8811E984-15F2-4D5D-A743-7DFE8BCA833E @default.
- Q99529969 P8363 Q99529969-32361B52-8464-45D7-8BFD-B06CE330EF71 @default.
- Q99529969 P859 Q99529969-81136EA6-8DB0-4DAF-B2A0-40DB9E027CE2 @default.
- Q99529969 P1132 "+34" @default.
- Q99529969 P1476 "Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel" @default.
- Q99529969 P17 Q30 @default.
- Q99529969 P2899 "+18" @default.
- Q99529969 P3098 "NCT04449549" @default.
- Q99529969 P31 Q30612 @default.
- Q99529969 P4135 "+120" @default.
- Q99529969 P4844 Q423762 @default.
- Q99529969 P580 "2020-08-24T00:00:00Z" @default.
- Q99529969 P582 "2024-04-02T00:00:00Z" @default.
- Q99529969 P6099 Q42824440 @default.
- Q99529969 P8005 Q76649708 @default.
- Q99529969 P8363 Q78089383 @default.
- Q99529969 P859 Q664846 @default.